BSPM
Biostar Pharmaceuticals, Inc.
BSPM
BSPM
Delisted
BSPM was delisted on the 18th of September, 2018.
0 hedge funds and large institutions have $0 invested in Biostar Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.
Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Acadian Asset Management
Boston,
Massachusetts
| – | – | -107,196 | Closed |
|
2
Barclays
London,
United Kingdom
| – | – | -18,300 | Closed |
|
3
Morgan Stanley
New York
| – | – | -3,950 | Closed |
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -3,500 | Closed |
|
|
IA
5
IFP Advisors
Tampa,
Florida
| – | – | -3,250 | Closed |
|
6
UBS Group
Zurich,
Switzerland
| – | – | -297 | Closed |
|